21hOpinion
The New Republic on MSNElon Musk’s DOGE Minions Have Found Their New Target: NASAMusk might also take aim at NASA’s other contracts to serve his interests. Last year, for example, he attacked Boeing over ...
22hOpinion
The New Republic on MSNRussia Asks Elon Musk for Help Crushing DissentSo far, Musk has taken a sledgehammer to the U.S. Agency for International Development, setting off alarm bells, and is ...
While Robert F. Kennedy Jr. ‘s Senate confirmation to head the Department of Health and Human Services was not unexpected, it ...
Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
The vaccine maker Moderna had no Valentine’s Day chocolates for investors when its fourth-quarter financial results came out ...
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.
Moderna Inc.’s stock fell 3% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered ...
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results